To join ISCTR, click HERE.

To subscribe to the ISCTR eTextbook, click HERE.

Already a member? Login

Follow us

  /  Part III.1 – Cellular and Gene Therapy for Cardiac Disease: FDA Product and Pre-Clinical Regulatory Considerations
  III.1 Cellular and Gene Therapy for Cardiac Disease: FDA Product and Pre-Clinical Regulatory Considerations Wei Liang PhD and Brent McCright PhD A. Introduction Heart failure and ischemic heart damage caused by coronary artery blockage are examples of cardiac diseases currently being evaluated for treatment with cellular […]